Blood glucose level changes by propofol & midazolam

Comparing changes in blood glucose level during and after cataract surgery with light sedation using propofol-fentanyl and midazolam-fentanyl in diabetic patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201501126115N2

Enrollment

Registered

2015-01-29

Start date

2013-08-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-insulin-dependent diabetes mellitus. Non-insulin-dependent diabetes of the young

Interventions

Intervention 1: Light sedation was performed using midazolam and fentanyl. Intervention 2: Light sedation was pefromed using propofol and fentanyl.

Treatment - Drugs

Light sedation was performed using midazolam and fentanyl.

Light sedation was pefromed using propofol and fentanyl.

Eligibility

Sex/Gender

All

Age

35 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Age of more than 35 years old; Having Diabetes type 2 for at least one-year; Being a candidate for cataract surgery; Patient's consent to join the study Exclusion criteria: Hemodynamically unstable patients (need for vasopressors during the study); Dying before the end of the intervention; Occurrence of clotting and bleeding disorders during the study; Need for general anesthesia because of surgery's complications and circumstances

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Blood glucose level. Timepoint: 30 minutes prior to the surgery, each 15 minutes during surgery and at the end of surgery. Method of measurement: Glucometer.	—

Secondary

Measure	Time frame
Heart rate. Timepoint: 30 minutes prior to the surgery, each 15 minutes during surgery and at the end of the surgery. Method of measurement: Monitoring.;Blood pressure. Timepoint: 30 minutes prior to the surgery, each 15 minutes during surgery and at the end of the surgery. Method of measurement: Monitoring.;Respiratory rate. Timepoint: 30 minutes prior to the surgery, each 15 minutes during surgery and at the end of the surgery. Method of measurement: Monitoring.;Oxygen saturation. Timepoint: 30 minutes prior to the surgery, each 15 minutes during surgery and at the end of the surgery. Method of measurement: Monitoring.;Coughs. Timepoint: Each 15 minutes during surgery. Method of measurement: Observation.;Fighting with ventilator. Timepoint: Each 15 minutes during surgery. Method of measurement: Observation.;Apnea. Timepoint: Each 15 minutes during surgery. Method of measurement: Monitoring.;Agitation. Timepoint: Each 15 minutes during the surgery and at the end of the surgery. Method of measurement: Observation.;Anxiety. Timepoint: Each 15 minutes during the surgery and at the end of the surgery. Method of measurement: Observation.;Weakness. Timepoint: Each 15 minutes during the surgery and at the end of the surgery. Method of measurement: Observation.;Headache. Timepoint: Each 15 minutes during the surgery and at the end of the surgery. Method of measurement: Observation.;Vertigo. Timepoint: Each 15 minutes during the surgery and at the end of the surgery. Method of measurement: Observation.;Nausea. Timepoint: Each 15 minutes during the surgery and at the end of the surgery. Method of measurement: Observation.;Vomiting. Timepoint: Each 15 minutes during the surgery and at the end of the surgery. Method of measurement: Observation.;Diuresis. Timepoint: Each 15 minutes during the surgery and at the end of the surgery. Method of measurement: Observation.;Respiratory distress. Timepoint: Each 15 minutes during the surgery and at the end of the surgery. Method of meas	—

Measure

Time frame

Heart rate. Timepoint: 30 minutes prior to the surgery, each 15 minutes during surgery and at the end of the surgery. Method of measurement: Monitoring.;Blood pressure. Timepoint: 30 minutes prior to the surgery, each 15 minutes during surgery and at the end of the surgery. Method of measurement: Monitoring.;Respiratory rate. Timepoint: 30 minutes prior to the surgery, each 15 minutes during surgery and at the end of the surgery. Method of measurement: Monitoring.;Oxygen saturation. Timepoint: 30 minutes prior to the surgery, each 15 minutes during surgery and at the end of the surgery. Method of measurement: Monitoring.;Coughs. Timepoint: Each 15 minutes during surgery. Method of measurement: Observation.;Fighting with ventilator. Timepoint: Each 15 minutes during surgery. Method of measurement: Observation.;Apnea. Timepoint: Each 15 minutes during surgery. Method of measurement: Monitoring.;Agitation. Timepoint: Each 15 minutes during the surgery and at the end of the surgery. Method of measurement: Observation.;Anxiety. Timepoint: Each 15 minutes during the surgery and at the end of the surgery. Method of measurement: Observation.;Weakness. Timepoint: Each 15 minutes during the surgery and at the end of the surgery. Method of measurement: Observation.;Headache. Timepoint: Each 15 minutes during the surgery and at the end of the surgery. Method of measurement: Observation.;Vertigo. Timepoint: Each 15 minutes during the surgery and at the end of the surgery. Method of measurement: Observation.;Nausea. Timepoint: Each 15 minutes during the surgery and at the end of the surgery. Method of measurement: Observation.;Vomiting. Timepoint: Each 15 minutes during the surgery and at the end of the surgery. Method of measurement: Observation.;Diuresis. Timepoint: Each 15 minutes during the surgery and at the end of the surgery. Method of measurement: Observation.;Respiratory distress. Timepoint: Each 15 minutes during the surgery and at the end of the surgery. Method of meas

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPooyan Khalighinejad

Isfahan University of Medical Sciences

pooyankh@outlook.com+98 31 3668 0042

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026